KNSA
Closed
Kiniksa Pharmaceuticals Ltd
27.24
-0.43 (-1.55%)
Last Update: 01 Jul 2025 23:00:00
Yesterday: 27.67
Day's Range: 27.24 - 27.9008
Send
sign up or login to leave a comment!
When Written:
10.71
Kiniksa Pharmaceuticals Ltd is a biopharmaceutical company that focuses on discovering, developing, and commercializing therapies for patients suffering from debilitating diseases with significant unmet medical need. The company's pipeline includes several product candidates, including rilonacept, mavrilimumab, and vixarelimab, which are being developed for the treatment of various inflammatory and autoimmune diseases. Kiniksa Pharmaceuticals was founded in 2015 and is headquartered in Hamilton, Bermuda, with additional offices in Lexington, Massachusetts, and London, United Kingdom. The company is listed on the NASDAQ stock exchange under the ticker symbol KNSA.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








